For Pancreatic Cancer, Biomarker Test Offers Chance for Early Detection

When cancer is detected,  the interaction of two nanoparticles creates a bright yellow signal (photo by Fei Lu, Houston Methodist Research Institute).

Pancreatic cancer is the fourth leading cause of cancer deaths in the United States each year, in part because around four-fifths of cases go undetected until they have reached an advanced stage. But a new, biomarker-based test could soon change all that — and offer a way to monitor treatment outcomes.

Read/listen to my full story at KJZZ’s Arizona Science Desk:
Biomarker Test Offers Hope For Early Detection Of Pancreatic Cancer

Leave a Reply